Tamar D Howson Receives Stock Award at Cue Biopharma Inc (CUE) — SEC Form 4, Jan 06, 2021

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Tamar D Howson

Director

TXN 2021-01-04 · FILED 2021-01-06

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Cue Biopharma Inc

CUE CIK 0001645460

Reporting Owner

Name	Relationship
Tamar D Howson CIK 0001202286	Director

Tamar D Howson at Cue Biopharma Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Cue Biopharma Inc

2023-01-05	Award	—	View
2022-01-05	Award	—	View

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Stock Option (right to buy)F1 F2	$12.36	2021-01-04	A - Award/Grant	10,000 A	$0.00	2031-01-03	10,000 Common Stock	Direct

Footnotes (2)

F1: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. Show more
F2: This option was granted on January 4, 2021. The shares underlying the option are scheduled to vest in full on the anniversary of the grant date. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Cue Biopharma Inc

GET /v1/forms/4/0000899243-21-000700 API docs